These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 9113450)

  • 1. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
    Creemers P; Brink J; Kahn D
    Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
    Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
    Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
    J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation.
    Lee KW; Kim SJ; Lee DS; Lee HH; Joh JW; Lee SK; Oh HY; Kim DJ; Kim YG; Huh WS; Oh WI; Lee BB
    Transplant Proc; 2004 Sep; 36(7):2009-10. PubMed ID: 15518726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era.
    Nwakanma LU; Williams JA; Weiss ES; Russell SD; Baumgartner WA; Conte JV
    Ann Thorac Surg; 2007 Nov; 84(5):1556-62; discussion 1562-3. PubMed ID: 17954062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal graft survival is not influenced by a positive flow B-cell crossmatch.
    Bryan CF; Wakefield M; Reese JC; Shield CF; Warady BA; Winklhofer FT; Murillo D
    Clin Transplant; 2007; 21(1):72-9. PubMed ID: 17302594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of peak and current serum panel-reactive antibody on graft survival.
    Premasathian N; Panorchan K; Vongwiwatana A; Pornpong C; Agadmeck S; Vejbaesya S
    Transplant Proc; 2008 Sep; 40(7):2200-1. PubMed ID: 18790191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization.
    Ogura K
    Clin Transpl; 1992; ():357-69. PubMed ID: 1306712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies.
    Opelz G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1570-6. PubMed ID: 15866311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.
    Wright EJ; Fiser WP; Edens RE; Frazier EA; Morrow WR; Imamura M; Jaquiss RD
    J Heart Lung Transplant; 2007 Nov; 26(11):1163-9. PubMed ID: 18022083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?
    Kobashigawa JA; Sabad A; Drinkwater D; Cogert GA; Moriguchi JD; Kawata N; Hamilton MA; Hage A; Terasaki P; Laks H
    Circulation; 1996 Nov; 94(9 Suppl):II294-7. PubMed ID: 8901763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK
    Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation.
    Lavee J; Kormos RL; Duquesnoy RJ; Zerbe TR; Armitage JM; Vanek M; Hardesty RL; Griffith BP
    J Heart Lung Transplant; 1991; 10(6):921-9; discussion 929-30. PubMed ID: 1756157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G-positive in B-cell cross-match decreases kidney allograft survival.
    Fagundes I; Michelon T; Schoroeder R; Fernandes S; Sporleder H; Canabarro R; Rodrigues H; Petry M; Zanenga D; Silveira J; Montagner J; Bortolotto A; Keitel E; Santos A; Garcia V; Neumann J
    Transplant Proc; 2005; 37(6):2753-4. PubMed ID: 16182801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.